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Fig. 1. Partial karyotypes of the translocation t(X;20)(q13;q13.3) for cases 1‚4 (top to bottom; see case report section). Arrows indicate 
the derivatives 20 and X. 
 
Clinics and pathology 
Disease 
Myelodysplastic syndromes (MDS): refractory anaemia  
with excess of blasts (RAEB-RAEBt), refractory  
anaemia (RA), MDS sideroblastic anemia and MDS 
pancytopenia and thrombocytopenia most often (5  
cases); polycytemia vera --> acute myeloid leukemia  
 
(AML)-M1; myelofibrosis --> acute leukemia. 
Epidemiology 
Only 7 cases to date and they are exclusively female: 0 
Male/7 Female; found in older patients (Median age 61 
years; range: 57-86). 
Clinics 
Still poorly known. 










Fig 2: X-centromere probe DXZ1 (green) hybridized to the normal X and the derivative X (arrows). The androgen receptor (Xq12) AR 
(red) probe hybridized to derivative 20 and the normal X (arrows). The breakpoint on the X chromosome is proximal to AR. The karyotype 
is 46, X, t(X;20)(q13;q13.3).ish t(X;20)(q11.2q12;q13.3)(wcpX+,wcp20+,AR?;wcp20+, D20S180?,AR+,wcpX+). The revised breakpoints 




Sole abnormality in 5 MDS cases and accompanying 
changes +8, +9, del(13)(q21) and der(1;7)(q10;p10) in 
2 cases that transformed to AML. 
Cytogenetics molecular 
By FISH the cytogenetic breakpoint was proximal to 
AR gene and hence the breakpoint on X chromosome is 
t(X;20)(q11.2q12;q13.3). 
To be noted 
Case Report 
Translocation (X;20)(q13;q13.3): a nonrandom 
abnormality in four patients with myeloid disorders: 
case 1 
Translocation (X;20)(q13;q13.3): a nonrandom 
abnormality in four patients with myeloid disorders: 
case 2 
Translocation (X;20)(q13;q13.3): a nonrandom 
abnormality in four patients with myeloid disorders: 
case 3 
Translocation (X;20)(q13;q13.3): a nonrandom 
abnormality in four patients with myeloid disorders: 
case 4 
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